Jennifer Chang

Jennifer Chang is an accomplished executive with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Executive Director of Market Access Strategy & Marketing at Iovance Biotherapeutics, Inc., Jennifer focuses on commercialization and launch readiness for T-cell cancer immunotherapy, overseeing initiatives in market access, case management, and patient support. Prior to this role, Jennifer worked at PwC as a Manager in Health Industries Advisory, guiding pharma and biotech companies on commercialization strategies. Experience at Amgen and GSK includes significant contributions to sales and training within oncology and immunology sectors, achieving high sales performance and numerous awards. Jennifer holds an MBA from UCLA Anderson School of Management and additional degrees in public health, biochemistry, and international studies from reputable institutions.